361 related articles for article (PubMed ID: 11606917)
1. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
Plunkett RW; Chiarello SE; Beutner EH
J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917
[TBL] [Abstract][Full Text] [Related]
2. Linear IgA bullous dermatosis induced by piroxicam.
Camilleri M; Pace JL
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):70-2. PubMed ID: 9552762
[TBL] [Abstract][Full Text] [Related]
3. Naproxen-associated linear IgA bullous dermatosis: case report and review.
Bouldin MB; Clowers-Webb HE; Davis JL; McEvoy MT; Davis MD
Mayo Clin Proc; 2000 Sep; 75(9):967-70. PubMed ID: 10994833
[TBL] [Abstract][Full Text] [Related]
4. [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients].
Denguezli M; Ben Nejma B; Nouira R; Korbi S; Bardi R; Ayed K; Essoussi AS; Jomaa B
Ann Dermatol Venereol; 1994; 121(12):888-92. PubMed ID: 7632006
[TBL] [Abstract][Full Text] [Related]
5. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
Billet SE; Kortuem KR; Gibson LE; El-Azhary R
Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
Jones DH; Todd M; Craig TJ
J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
[TBL] [Abstract][Full Text] [Related]
8. Linear IgA bullous dermatosis induced by atorvastatin.
König C; Eickert A; Scharfetter-Kochanek K; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2001 Apr; 44(4):689-92. PubMed ID: 11260550
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
Waldman MA; Black DR; Callen JP
Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
[TBL] [Abstract][Full Text] [Related]
10. Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature.
Panasiti V; Rossi M; Devirgiliis V; Curzio M; Bottoni U; Calvieri S
Int J Dermatol; 2009 Sep; 48(9):1006-10. PubMed ID: 19702992
[TBL] [Abstract][Full Text] [Related]
11. Linear IgA bullous dermatosis following influenza vaccination.
Alberta-Wszolek L; Mousette AM; Mahalingam M; Levin NA
Dermatol Online J; 2009 Nov; 15(11):3. PubMed ID: 19951639
[TBL] [Abstract][Full Text] [Related]
12. Linear IgA bullous dermatosis of childhood: a long-term study.
Kulthanan K; Akaraphanth R; Piamphongsant T; Kullavanijaya P
J Med Assoc Thai; 1999 Jul; 82(7):707-12. PubMed ID: 10511773
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
Cummings JE; Snyder RR; Kelly EB; Raimer SS
Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585
[TBL] [Abstract][Full Text] [Related]
14. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
Watanabe M; Tsunoda T; Tagami H
Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
Kuechle MK; Stegemeir E; Maynard B; Gibson LE; Leiferman KM; Peters MS
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):187-92. PubMed ID: 7904616
[TBL] [Abstract][Full Text] [Related]
16. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
Kovacic D; Fox M; Reichenberg J
J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
[TBL] [Abstract][Full Text] [Related]
18. Linear IgA bullous dermatosis. An immunologically defined disease.
Wilson BD; Beutner EH; Kumar V; Chorzelski TP; Jablonska S
Int J Dermatol; 1985 Nov; 24(9):569-74. PubMed ID: 3905638
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
20. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
Ho JC; Ng PL; Tan SH; Giam YC
Pediatr Dermatol; 2007; 24(5):E40-3. PubMed ID: 17958778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]